pharmaceutical quality system – Pharma GMP

GxP Quality Systems: A Step-by-Step, Inspection-Ready Guide to PQS, Training & Professional Development — PharmaGMP

digi — Mon, 03 Nov 2025 11:37:53 +0000

GxP Quality Systems: A Step-by-Step, Inspection-Ready Guide to PQS, Training & Professional Development — PharmaGMP GxP Quality Systems — Step-by-Step Guide to PQS, Training & Professional Development GxP quality systems turn regulatory requirements into reliable behavior across the plant, lab, and supply chain. This pillar article provides a practical, inspection-ready pattern for designing and operating...

cGMP Regulations: A Step-by-Step, Inspection-Ready Guide to US/EU/UK/Global GMP — PharmaGMP

digi — Sat, 01 Nov 2025 15:12:00 +0000

cGMP Regulations: A Step-by-Step, Inspection-Ready Guide to US/EU/UK/Global GMP — PharmaGMP cGMP Regulations — Step-by-Step, Inspection-Ready Guide to US/EU/UK/Global GMP Current Good Manufacturing Practice (cGMP regulations) convert quality principles into daily behaviors that deliver medicines that are safe, effective, and consistently manufactured. This pillar guide shows how to operationalize the core legal requirements across the...

Preparing for a Surprise FDA Inspection: Complete SOP

digi — Thu, 04 Sep 2025 04:07:32 +0000

Preparing for a Surprise FDA Inspection: Complete SOP Comprehensive SOP for Handling Surprise FDA Inspections Introduction: Why This Topic Matters for GMP Compliance FDA inspections are designed to ensure that pharmaceutical manufacturers consistently comply with Good Manufacturing Practices (GMP). While some inspections are pre-announced, many are unannounced or “surprise” inspections. These inspections test a company’s...

Root Cause Analysis for GMP Non-Conformities

digi — Wed, 03 Sep 2025 06:00:35 +0000

Root Cause Analysis for GMP Non-Conformities Effective Root Cause Analysis for GMP Non-Conformities Introduction: Why This Topic Matters for GMP Compliance Non-conformities in Good Manufacturing Practice (GMP) are inevitable in complex pharmaceutical manufacturing environments. Deviations, failures, and unexpected outcomes occur despite best efforts. Regulatory bodies such as the FDA, EMA, and WHO expect that when...

Conduct Periodic Pest Control Audits in GMP Storage Areas

digi — Tue, 06 May 2025 19:09:27 +0000

Conduct Periodic Pest Control Audits in GMP Storage Areas Schedule Regular Pest Control Audits in GMP Warehouses Remember: Routine pest control audits are crucial to preventing contamination and ensuring compliance in pharmaceutical storage areas. Why This Matters in GMP Pests pose a significant risk to pharmaceutical products. Rodents, insects, and birds can damage packaging, introduce...

Conduct Risk Assessments Before Implementing Process Changes

digi — Thu, 01 May 2025 23:15:52 +0000

Conduct Risk Assessments Before Implementing Process Changes Ensure Risk Assessment Precedes Any Change in Manufacturing Process Remember: Never initiate process changes without first conducting a documented risk assessment. Why This Matters in GMP In the pharmaceutical industry, even minor changes to a manufacturing process can have significant consequences. A change that appears harmless may introduce...

Conduct Risk Assessments Before Implementing Process Changes

digi — Thu, 01 May 2025 10:09:00 +0000